Sara Linse Awarded 10MDKK from the Novo Nordisk Foundation
Published 9 May 2019 Sara Linse has been awarded 10 MDKK from the Novo Nordisk Foundation for her project entitled "Unravelling the IAPP aggregation mechanism for the design of inhibitors that specifically suppress toxicity and cell death in type 2 diabetes" as part of the Foundation’ Research Leader Programme, which supports ambitious, original research projects and the continuing development of
https://www.nano.lu.se/article/sara-linse-awarded-10mdkk-novo-nordisk-foundation - 2025-01-12